L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale.

Translated title of the contribution: CCNU in the chemotherapy of tumours of the central nervous system (author's transl)

D. Adinolfi, L. Pavesi, G. Robustelli della Cuna, P. Paoletti

Research output: Contribution to journalArticle

Abstract

This study concerns 59 patients with primary and metastatic tumors of the CNS. After surgery, each patients followed a therapeutic protocol requiring Radiotherapy (5500 Rads for 6 weeks) and antiblastic monochemotherapy with CCNU (130 MG/M2/D p.o. every 8 weeks). The results were evaluated according to Wilson's (1975) criteria of response to therapy. CCNU significantly improved the survival time in comparison to the data given for conventional treatment.

Translated title of the contributionCCNU in the chemotherapy of tumours of the central nervous system (author's transl)
Original languageItalian
Pages (from-to)191-195
Number of pages5
JournalRivista di Patologia Nervosa e Mentale
Volume98
Issue number3
Publication statusPublished - May 1977

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'CCNU in the chemotherapy of tumours of the central nervous system (author's transl)'. Together they form a unique fingerprint.

  • Cite this

    Adinolfi, D., Pavesi, L., Robustelli della Cuna, G., & Paoletti, P. (1977). L'uso del CCNU nella chemioterapia dei tumori del sistema nervoso centrale. Rivista di Patologia Nervosa e Mentale, 98(3), 191-195.